Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (Q42182888)

18 October 2017

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy (English)

1 reference

18 October 2017

1 reference

1

1 reference

18 October 2017

15

1 reference

18 October 2017

47

1 reference

18 October 2017

Dalil Hannani

12

0 references

Oliver Kepp

Oliver Kepp

16

0 references

Guido Kroemer

Guido Kroemer

50

0 references

Laurence Zitvogel

51

Laurence Zitvogel

1 reference

18 October 2017

26

Magali Lacroix-Triki

1 reference

Frédérique Penault-Llorca

18 October 2017

33

Frederique Penault-Llorca

1 reference

18 October 2017

32

Suzette Delaloge

1 reference

18 October 2017

38

Alexander Eggermont

1 reference

18 October 2017

7

Ilio Vitale

1 reference

18 October 2017

3

Erika Vacchelli

0 references

Vichnou Poirier-Colame

31

Vichnou Poirier-Colame

1 reference

18 October 2017

49

Fabrice André

1 reference

18 October 2017

Laura Bracci

20

0 references

Paola Sestili

Paola Sestili

23

0 references

Enrico Proietti

Enrico Proietti

48

0 references

Filippo Belardelli

Filippo Belardelli

19

0 references

Catarina Remédios

Catarina Remédios

10

0 references

Joachim Schultze

17

Joachim L Schultze

1 reference

18 October 2017

40

Mikael Pittet

1 reference

18 October 2017

5

David P Enot

1 reference

18 October 2017

42

Christina Pfirschke

1 reference

18 October 2017

41

Camilla Engblom

1 reference

18 October 2017

28

Rosa Conforti

1 reference

18 October 2017

11

Laetitia Fend

1 reference

18 October 2017

13

Laetitia Aymeric

1 reference

18 October 2017

4

Kariman Chaba

1 reference

18 October 2017

35

Laurent Arnould

1 reference

18 October 2017

8

Aicha Goubar

1 reference

18 October 2017

9

Elisa E Baracco

1 reference

18 October 2017

45

Robert D Schreiber

1 reference

18 October 2017

Takahiro Yamazaki

2

1 reference

18 October 2017

Julien Adam

6

1 reference

18 October 2017

Yuting Ma

14

1 reference

18 October 2017

Thomas Tüting

18

1 reference

18 October 2017

Valentina La Sorsa

21

1 reference

18 October 2017

Giovanna Ziccheddu

22

1 reference

18 October 2017

Francesca Urbani

24

1 reference

18 October 2017

Mauro Delorenzi

25

1 reference

18 October 2017

Virginie Quidville

27

1 reference

18 October 2017

Jean-Philippe Spano

29

1 reference

18 October 2017

Lajos Pusztai

30

1 reference

18 October 2017

Sylvain Ladoire

34

1 reference

18 October 2017

Joanna Cyrta

36

1 reference

18 October 2017

Marie-Charlotte Dessoliers

37

1 reference

18 October 2017

Marco E Bianchi

39

1 reference

18 October 2017

Xavier Préville

43

1 reference

18 October 2017

Gilles Uzè

44

1 reference

18 October 2017

Melvyn T Chow

46

1 reference

18 October 2017

language of work or name

English

0 references

publication date

26 October 2014

1 reference

18 October 2017

1 reference

18 October 2017

20

1 reference

18 October 2017

1301-1309

1 reference

18 October 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm.3708

18 October 2017

0 references

cites work

Immunogenic cell death in cancer therapy

1 reference

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

21 January 2018

1 reference

The unfolded protein response: integrating stress signals through the stress sensor IRE1α

21 January 2018

1 reference

Autophagy in immunity and inflammation

21 January 2018

1 reference

The danger model: a renewed sense of self

21 January 2018

1 reference

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

21 January 2018

1 reference

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

An immunosurveillance mechanism controls cancer cell ploidy

21 January 2018

1 reference

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy

21 January 2018

1 reference

The function and evolution of the restriction factor Viperin in primates was not driven by lentiviruses

21 January 2018

1 reference

Interferons, Mx genes, and resistance to influenza virus

21 January 2018

1 reference

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition

21 January 2018

1 reference

Crystal structure of IFIT2 (ISG54) predicts functional properties of IFITs

21 January 2018

1 reference

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus

21 January 2018

1 reference

Nucleic acid recognition by the innate immune system

21 January 2018

1 reference

Cytosolic sensing of viruses

21 January 2018

1 reference

Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection

21 January 2018

1 reference

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

21 January 2018

1 reference

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

21 January 2018

1 reference

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

21 January 2018

1 reference

Multifactorial approach to predicting resistance to anthracyclines

21 January 2018

1 reference

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

21 January 2018

1 reference

Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1146 patients with early breast cancer

21 January 2018

1 reference

Trastuzumab for patients with axillary-node-positive breast cancer: results of the FNCLCC-PACS 04 trial

21 January 2018

1 reference

Interferon-inducible effector mechanisms in cell-autonomous immunity

21 January 2018

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA.

21 January 2018

1 reference

The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells

21 January 2018

1 reference

Ultraviolet radiation damages self noncoding RNA and is detected by TLR3.

21 January 2018

1 reference

Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics

21 January 2018

1 reference

Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer

21 January 2018

1 reference

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Natural innate and adaptive immunity to cancer

21 January 2018

1 reference

Influence of genetic variants in type I interferon genes on melanoma survival and therapy

21 January 2018

1 reference

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

21 January 2018

1 reference

Type I interferon is selectively required by dendritic cells for immune rejection of tumors

21 January 2018

1 reference

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

21 January 2018

1 reference

Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.

21 January 2018

1 reference

Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.

21 January 2018

1 reference

Leukocyte composition of human breast cancer

21 January 2018

1 reference

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

21 January 2018

1 reference

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

21 January 2018

1 reference

STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

21 January 2018

1 reference

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

21 January 2018

1 reference

Blocking Monoclonal Antibodies Specific for Mouse IFN-α/β Receptor Subunit 1 (IFNAR-1) from Mice Immunized by In Vivo Hydrodynamic Transfection

21 January 2018

1 reference

Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody

21 January 2018

1 reference

Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses

21 January 2018

1 reference

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins

21 January 2018

1 reference

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

21 January 2018

1 reference

Cell death assays for drug discovery

21 January 2018

1 reference

Mitochondrial control of cell death induced by hyperosmotic stress

21 January 2018

1 reference

IlluminaGUI: graphical user interface for analyzing gene expression data generated on the Illumina platform

21 January 2018

1 reference

Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue

21 January 2018

1 reference

Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

21 January 2018

1 reference

Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies

21 January 2018

1 reference

12 December 2020

Biomarker analysis of neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or Paclitaxel in early-stage breast cancer

1 reference

12 December 2020

A method for the large scale production of potent interferon preparations.

1 reference

12 December 2020

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

12 December 2020

Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study

1 reference

12 December 2020

Decoding cell death signals in inflammation and immunity

1 reference

12 December 2020

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

1 reference

12 December 2020

Immunomodulatory functions of type I interferons

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.3708

1 reference

18 October 2017

1 reference